FDA Inspection 1244125 — Nubratori, Inc

Nubratori, Inc — FEI 3010166491

The FDA completed an inspection of Nubratori, Inc on July 26, 2024 in Torrance, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)

Citations

IDCFRDescription
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143521 CFR 211.42(c)(10)(v)Cleaning System
145221 CFR 211.113(b)Validation lacking for sterile drug products
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A
184921 CFR 211.84(d)(6)Objectionable microbiological contamination
22779FDCA 503B(b)(2)(A)All inclusive product report, not submitted
361621 CFR 211.165(d)Acceptance criteria for sampling & testing